Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 7/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | REN | P00797 | 1/20 | 0.49 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.48 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.48 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19024815 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL10756784 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL15650301 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL5036114 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL2635952 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL5033212 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL15649718 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL2635949 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL21853572 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL19024591 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113262175-B | Skin care compositions and methods of use thereof | 尤尼根公司 | 2024-04-16 | — | — | CN | claimed |
| EP-4138770-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | Henkel AG & Co. KGaA (DE) | 2023-03-01 | — | — | EP | claimed |
| CN-115427007-A | Transparent shampoo block and preparation method thereof | 汉高股份有限及两合公司 | 2022-12-02 | — | — | CN | claimed |
| US-11446225-B2 | Skin care compositions and methods of use thereof | UNIGEN, INC. (US) | 2022-09-20 | — | — | US | claimed |
| WO-2021212404-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | HENKEL AG & CO. KGAA (DE) | 2021-10-28 | — | — | WO | claimed |
| CN-113262175-A | Skin care compositions and methods of use thereof | 尤尼根公司 | 2021-08-17 | — | — | CN | claimed |
| US-20210087250-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TRANSMUCOSAL DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS | CYPRUMED GMBH (AT) | 2021-03-25 | — | — | US | claimed |
| EP-3006045-B3 | Pharmaceutical formulations for the oral delivery of peptide or protein drugs | CYPRUMED GMBH (AT) | 2021-03-17 | — | — | EP | claimed |
| EP-3773475-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TRANSMUCOSAL DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS | Cyprumed GmbH (AT) | 2021-02-17 | — | — | EP | claimed |
| CN-105873564-B | Skin care compositions and methods of use thereof | 尤尼根公司 | 2021-01-19 | — | — | CN | claimed |
| EP-3062767-A1 | SKIN CARE COMPOSITIONS AND METHODS OF USE THEREOF | Unigen, Inc. (US) | 2016-09-07 | — | — | EP | claimed |
| CN-105873564-A | Skin care compositions and methods of use thereof | 尤尼根公司 | 2016-08-17 | — | — | CN | claimed |
| WO-2016055550-A1 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE OR PROTEIN DRUGS | CYPRUMED GMBH (AT) | 2016-04-14 | — | — | WO | claimed |
| EP-3006045-A1 | Pharmaceutical formulations for the oral delivery of peptide or protein drugs | Cyprumed GmbH (AT) | 2016-04-13 | — | — | EP | claimed |
| WO-2015066352-A1 | SKIN CARE COMPOSITIONS AND METHODS OF USE THEREOF | UNIGEN, INC. (US) | 2015-05-07 | — | — | WO | claimed |
| US-20140056953-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | NOVO NORDISK A/S (DK) | 2014-02-27 | — | — | US | claimed |
| EP-2696847-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | Novo Nordisk A/S (DK) | 2014-02-19 | — | — | EP | claimed |
| WO-2012140155-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | NOVO NORDISK A/S (DK) | 2012-10-18 | — | — | WO | claimed |
| WO-2011141685-A2 | SYSTEMIC NASAL COMPOSITIONS COMPRISING COCOYL PROLINE OR AT LEAST ONE OF THE CONSTITUENTS THEREOF | PHYSICA PHARMA SAS (FR) | 2011-11-17 | — | — | WO | claimed |
| WO-1996018895-A9 | CHIRAL SEPARATION OF ENANTIOMERS BY HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY | — | 1996-10-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11446225-B2 | Skin care compositions and methods of use thereof | CUTA, LGALS8, RBP1 | ACE 956/4885ACE2 2056/4885L3MBTL1 1436/4885 |
| US-20210087250-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TRANSMUCOSAL DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS | VIP, PTMS, VASP | ACE 3715/4885ACE2 3285/4885L3MBTL1 4790/4885 |
| US-20140056953-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | SLC27A1, SLC27A2, FABP2 | ACE 496/4885ACE2 613/4885L3MBTL1 4285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.